{"id":"W2883058590","doi":"10.1371/journal.pone.0199575","title":"Comparative efficacy and safety of licensed treatments for previously treated non-small cell lung cancer: A systematic review and network meta-analysis","year":2018,"lang":"en","type":"review","venue":"PLoS ONE","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Ottawa","funders":"National Institute for Health and Care Research","keywords":"Atezolizumab; Medicine; Nivolumab; Docetaxel; Internal medicine; Pembrolizumab; Oncology; Adverse effect; Erlotinib; Ramucirumab; Meta-analysis; Lung cancer; Hazard ratio; Cancer; Confidence interval; Epidermal growth factor receptor; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02170537,0.003299283,0.02258758,0.007833369,0.0006264619,0.003720632,0.002359968,0.002428136,0.003421242],"category_scores_gemma":[0.05414381,0.001660043,0.0450266,0.006711666,0.0009660213,0.002209426,0.00162605,0.002005107,0.0003191071],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003984296,"about_ca_system_score_gemma":0.003886804,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006741997,"about_ca_topic_score_gemma":0.01270294,"domain_scores_codex":[0.9782551,0.01264126,0.005024218,0.001912666,0.001771152,0.0003955167],"domain_scores_gemma":[0.9704657,0.02255482,0.004412896,0.0008534218,0.001453368,0.0002597663],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.001508408,0.00002134909,0.002086534,0.2334939,0.7560714,0.00005851756,0.00004558608,0.0004942863,0.000116729,0.000111002,0.0002363522,0.005755841],"study_design_scores_gemma":[0.0006847808,0.0001757735,0.001611769,0.01643331,0.979782,0.00005569116,0.00002373787,0.0001948581,0.00007627354,0.0001869621,0.0007586551,0.00001618128],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.006172352,0.9909337,0.0009743111,0.0002507448,0.0002031298,0.0005560821,0.0005639975,0.00003379709,0.0003119956],"genre_scores_gemma":[0.3181326,0.6700256,0.005408641,0.001367769,0.0004330121,0.002997475,0.001202381,0.0000554684,0.0003769934],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.02258758,"threshold_uncertainty_score":0.1147904,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1766601193131163,"score_gpt":0.3605478071967952,"score_spread":0.183887687883679,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}